CD28 and cancer: Senescent T cells exhibit abnormal phenotypes, including downregulation of costimulatory molecules such as CD27 and CD28, and upregulation of killer cell lectin‐like receptor subfamily G, CD57, Tim‐3, and cytotoxic T‐lymphocyte‐associated protein 4, which are closely related to malignant tumors.16